NEW YORK, Dec. 13, 2016 -- BlindedByTheLight.com today announces the auction of Bruce Springsteen’s 1957 Chevrolet Bel Air Convertible where he wrote his signature songs “Born To Run,” “Thunder Road” and “Backstreets.” The original vehicle registration, temporary insurance card, and Allstate insurance card issued in Springsteen’s name and address are included with the car.
|
|||||
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/6ac41cd0-9764-4423-8686-e0d116b95647
After the release of Bruce’s record “Born To Run,” the car was featured in the October issues of both Time and Newsweek magazines, ironically both on page 57.
The car is also featured in Bruce’s autobiography titled, “Songs.” He writes, “In ‘70’s New Jersey, the car was still a powerful image. That summer I bought my first set of wheels for two thousand dollars. It was a ‘57 Chevy with dual, four-barrel carbs, a Hurst on the floor and orange flames spread across the hood.”
From October 2008 to January 2010, the Chevy was featured in the Rock n’ Roll Hall of Fame Annex in New York City quickly becoming the most popular artifact in the museum.
In January 2010, the Chevy was moved to the main Rock n' Roll Hall of Fame in Cleveland, OH where it became part of the largest Bruce Springsteen exhibit ever.
The car is in great running condition since the electrical and mechanical systems have been overhauled; the body and frame are untouched just the way it was when Bruce owned it.
A detailed color book has been compiled by the owner and noted Bruce Springsteen historian, Michael Crane, entitled "Out in the Street: Bruce Springsteen's 1957 Chevrolet Bel Air Convertible" (80 pages) is included in the sale. The book documents ownership, history of the vehicle, the appraisal, and includes many rare photographs never seen before.
Link to Auction: http://www.ebay.com/itm/272484092740
About BlindedByTheLight.com
BlindedByTheLight.com was founded by Michael Crane, who has been an ardent fan of Bruce's since he was seven years old. Crane, who is a recognized Bruce Springsteen historian (contributing to exhibits in both The Rock and Roll Hall of Fame in Cleveland, Ohio and the Rock Annex in New York City), created BBTL.com as a "one-stop shop" for all that is best about Bruce. Created by a fan for fans, it grants them the unique opportunity of having a totally intimate viewing experience with the quintessential rock legend of our time from the convenience of a computer, tablet or Smartphone.
Contact: Susan Blond Susan Blond Group, Inc. 212-333-7728, ext. 101 [email protected] Joshua Plant Susan Blond Group, Inc. 646-853-0609 [email protected]


Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland 



